Dechert advised Roche and Foundation Medicine in their partnership. Roche and Foundation Medicine announced their partnership with Gustave Roussy, the leading cancer center in Europe, to...
You must be a Standard 1 Year member to access this content.
Fréget Glaser & Associés assisted the Novartis laboratory in its appeal against the Competition Authority’s decision. The Roche laboratory was advised by Dechert LLP. Novartis has...
You must be a Standard 1 Year member to access this content.
Dechert advised Havea. PwC Société d’Avocats carried out tax due diligence on behalf of Havea Group. Havea Group has announced that it has entered into exclusive negotiations...
You must be a Standard 1 Year member to access this content.
Dechert advised Cathay Capital on the deal. Clifford Chance advised Gland Pharma. Indian generic injectables maker Gland Pharma Ltd (GLAD.NS) announced it will buy privately held French...
You must be a Standard 1 Year member to access this content.
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
You must be a Standard 1 Year member to access this content.
Deloitte | Taj et M&A Transaction Services and Dechert advised Mayoly Spindler, while Allen & Overy advised Ipsen. Weil Gotshal & Manges advised Caravelle and Capza...
You must be a Standard 1 Year member to access this content.
The Paul Hastings team advised the shareholders of Carso, while Dechert advised ArchiMed on the deal. ArchiMed, a leading investment firm exclusively dedicated to the healthcare...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz and Darrois Villey Maillot Brochier advise Perrigo, while Latham & Watkins served as the selling shareholders’ legal counsel and Dechert, as...
You must be a Standard 1 Year member to access this content.
KPMG Avocats advised ISAI and Sagard NewGen, while Dechert advised Stéphane Allez and Rémi Lacour, founders of Invoke. Invoke completed its takeover by the funds ISAI Expansion...
You must be a Standard 1 Year member to access this content.
